This undated file image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer's disease. A dramatic shift is beginning in the disappointing struggle to find something to slow the damage of Alzheimer's disease: The first U.S. experiments with “brain pacemakers” for Alzheimer's are getting underway. Scientists are looking beyond drugs to implants in the hunt for much-needed new treatments. There is no known cause or cure for Alzheimer’s disease.
This undated file image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer's disease. A dramatic shift is beginning in the disappointing struggle to find something to slow the damage of Alzheimer's disease: The first U.S. experiments with “brain pacemakers” for Alzheimer's are getting underway. Scientists are looking beyond drugs to implants in the hunt for much-needed new treatments. There is no known cause or cure for Alzheimer’s disease. File photo The Associated Press
This undated file image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer's disease. A dramatic shift is beginning in the disappointing struggle to find something to slow the damage of Alzheimer's disease: The first U.S. experiments with “brain pacemakers” for Alzheimer's are getting underway. Scientists are looking beyond drugs to implants in the hunt for much-needed new treatments. There is no known cause or cure for Alzheimer’s disease. File photo The Associated Press

Disparity in alerting people diagnosed with Alzheimer’s disease alarming

March 25, 2015 1:50 PM